Compounds > goniodiol
Page last updated: 2024-12-08

goniodiol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

goniodiol: from Malaysian medicinal plant; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID180702
CHEMBL ID490371
SCHEMBL ID2329557
MeSH IDM0414469

Synonyms (14)

Synonym
(2r)-2-[(1r,2r)-1,2-dihydroxy-2-phenylethyl]-2,3-dihydropyran-6-one
goniodiol
CHEMBL490371
96422-52-5
(+)-goniodiol
SCHEMBL2329557
DTXSID70242253
AKOS032948955
FS-8637
2h-pyran-2-one, 6-[(1r,2r)-1,2-dihydroxy-2-phenylethyl]-5,6-dihydro-,(6r)-
(6r)-6-[(1r,2r)-1,2-dihydroxy-2-phenylethyl]-5,6-dihydro-2h-pyran-2-one
HY-N3964
CS-0024530
(r)-6-((1r,2r)-1,2-dihydroxy-2-phenylethyl)-5,6-dihydro-2h-pyran-2-one
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (7)

Assay IDTitleYearJournalArticle
AID1327607Cytotoxicity against human A549 cells2016Journal of natural products, 08-26, Volume: 79, Issue:8
Biosynthesis-Inspired Total Synthesis of Bioactive Styryllactones (+)-Goniodiol, (6S,7S,8S)-Goniodiol, (-)-Parvistone D, and (+)-Parvistone E.
AID338112Cytotoxicity against human A549 cells
AID1327608Cytotoxicity against mouse P388 cells2016Journal of natural products, 08-26, Volume: 79, Issue:8
Biosynthesis-Inspired Total Synthesis of Bioactive Styryllactones (+)-Goniodiol, (6S,7S,8S)-Goniodiol, (-)-Parvistone D, and (+)-Parvistone E.
AID338111Toxicity against brine shrimp
AID338113Cytotoxicity against human MCF7 cells
AID338114Cytotoxicity against human HT-29 cells
AID338395Cytotoxicity against human A549 cells
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (71.43)29.6817
2010's1 (14.29)24.3611
2020's1 (14.29)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
ether
Ether: A mobile, very volatile, highly flammable liquid used as an inhalation anesthetic and as a solvent for waxes, fats, oils, perfumes, alkaloids, and gums. It is mildly irritating to skin and mucous membranes.. ether : An organooxygen compound with formula ROR, where R is not hydrogen.. diethyl ether : An ether in which the oxygen atom is linked to two ethyl groups.		2.0310ether;
volatile organic compound		inhalation anaesthetic;
non-polar solvent;
refrigerant
glycidol
glycidol: structure given in first source		2.0310epoxide;
primary alcohol
alkenes
[no description available]		2.0410
Harringtonine
harringtonin: alkaloid C from Caphalotaxus fortunei		2.0310alkaloid
altholactone
altholactone: structure in first source		2.0310furopyran
goniothalamin
goniothalamin: has antineoplastic activity; structure given in first source		2.4520
ConditionIndicatedRelationship StrengthStudiesTrials